These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

865 related items for PubMed ID: 10389921

  • 21. Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling.
    Linkov F, Lisovich A, Yurkovetsky Z, Marrangoni A, Velikokhatnaya L, Nolen B, Winans M, Bigbee W, Siegfried J, Lokshin A, Ferris RL.
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):102-7. PubMed ID: 17220337
    [Abstract] [Full Text] [Related]

  • 22. Defining cancer cachexia in head and neck squamous cell carcinoma.
    Richey LM, George JR, Couch ME, Kanapkey BK, Yin X, Cannon T, Stewart PW, Weissler MC, Shores CG.
    Clin Cancer Res; 2007 Nov 15; 13(22 Pt 1):6561-7. PubMed ID: 18006755
    [Abstract] [Full Text] [Related]

  • 23. Expression of IL-18 in patients with head and neck squamous cell carcinoma.
    Riedel F, Adam S, Feick P, Haas S, Götte K, Hörmann K, Mannheim Alcohol Study Group.
    Int J Mol Med; 2004 Feb 15; 13(2):267-72. PubMed ID: 14719133
    [Abstract] [Full Text] [Related]

  • 24. Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer.
    Jebreel A, Mistry D, Loke D, Dunn G, Hough V, Oliver K, Stafford N, Greenman J.
    J Laryngol Otol; 2007 Mar 15; 121(3):246-52. PubMed ID: 17040593
    [Abstract] [Full Text] [Related]

  • 25. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma.
    Riedel F, Zaiss I, Herzog D, Götte K, Naim R, Hörmann K.
    Anticancer Res; 2005 Mar 15; 25(4):2761-5. PubMed ID: 16080523
    [Abstract] [Full Text] [Related]

  • 26. Expression of vascular endothelial growth factor in human hepatocellular carcinoma.
    Yamaguchi R, Yano H, Iemura A, Ogasawara S, Haramaki M, Kojiro M.
    Hepatology; 1998 Jul 15; 28(1):68-77. PubMed ID: 9657098
    [Abstract] [Full Text] [Related]

  • 27. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
    Kato H, Yoshikawa M, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Tsukada K, Kuwano H.
    Anticancer Res; 2002 Jul 15; 22(6C):3977-84. PubMed ID: 12553021
    [Abstract] [Full Text] [Related]

  • 28. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo.
    Gutschalk CM, Herold-Mende CC, Fusenig NE, Mueller MM.
    Cancer Res; 2006 Aug 15; 66(16):8026-36. PubMed ID: 16912178
    [Abstract] [Full Text] [Related]

  • 29. Dual role of VEGF family members in the pathogenesis of head and neck cancer (HNSCC): possible link between angiogenesis and immune tolerance.
    Strauss L, Volland D, Kunkel M, Reichert TE.
    Med Sci Monit; 2005 Aug 15; 11(8):BR280-92. PubMed ID: 16049374
    [Abstract] [Full Text] [Related]

  • 30. Expression of vascular endothelial growth factor receptors on tumor cells in head and neck squamous cell carcinoma.
    Lalla RV, Boisoneau DS, Spiro JD, Kreutzer DL.
    Arch Otolaryngol Head Neck Surg; 2003 Aug 15; 129(8):882-8. PubMed ID: 12925349
    [Abstract] [Full Text] [Related]

  • 31. Antisense RNA to eIF4E suppresses oncogenic properties of a head and neck squamous cell carcinoma cell line.
    DeFatta RJ, Nathan CO, De Benedetti A.
    Laryngoscope; 2000 Jun 15; 110(6):928-33. PubMed ID: 10852506
    [Abstract] [Full Text] [Related]

  • 32. Vascular endothelial growth factor receptor 2 (VEGFR2) expression in squamous cell carcinomas of the head and neck.
    Neuchrist C, Erovic BM, Handisurya A, Steiner GE, Rockwell P, Gedlicka C, Burian M.
    Laryngoscope; 2001 Oct 15; 111(10):1834-41. PubMed ID: 11801954
    [Abstract] [Full Text] [Related]

  • 33. Influence of interleukin-1alpha on androgen receptor expression and cytokine secretion by cultured human dermal papilla cells.
    Boivin WA, Jiang H, Utting OB, Hunt DW.
    Exp Dermatol; 2006 Oct 15; 15(10):784-93. PubMed ID: 16984260
    [Abstract] [Full Text] [Related]

  • 34. Assessment of the VEGF, bFGF, aFGF and IL8 angiogenic activity in urinary bladder carcinoma, using the mice cutaneous angiogenesis test.
    Rogala E, Skopińska-Rózewska E, Sommer E, Pastewka K, Chorostowska-Wynimko J, Sokolnicka I, Kazoń M.
    Anticancer Res; 2001 Oct 15; 21(6B):4259-63. PubMed ID: 11908679
    [Abstract] [Full Text] [Related]

  • 35. Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines.
    Bancroft CC, Chen Z, Yeh J, Sunwoo JB, Yeh NT, Jackson S, Jackson C, Van Waes C.
    Int J Cancer; 2002 Jun 01; 99(4):538-48. PubMed ID: 11992543
    [Abstract] [Full Text] [Related]

  • 36. Correlation of cyclooxygenase-2 pathway and VEGF expression in head and neck squamous cell carcinoma.
    Lim SC, Park SY, Do NY.
    Oncol Rep; 2003 Jun 01; 10(5):1073-9. PubMed ID: 12883661
    [Abstract] [Full Text] [Related]

  • 37. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
    Alexandrakis MG, Passam FH, Boula A, Christophoridou A, Aloizos G, Roussou P, Kyriakou DS.
    Ann Hematol; 2003 Jan 01; 82(1):19-23. PubMed ID: 12574959
    [Abstract] [Full Text] [Related]

  • 38. Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways.
    Bancroft CC, Chen Z, Dong G, Sunwoo JB, Yeh N, Park C, Van Waes C.
    Clin Cancer Res; 2001 Feb 01; 7(2):435-42. PubMed ID: 11234901
    [Abstract] [Full Text] [Related]

  • 39. Phase I study of intraperitoneal recombinant human interleukin 12 in patients with Müllerian carcinoma, gastrointestinal primary malignancies, and mesothelioma.
    Lenzi R, Rosenblum M, Verschraegen C, Kudelka AP, Kavanagh JJ, Hicks ME, Lang EA, Nash MA, Levy LB, Garcia ME, Platsoucas CD, Abbruzzese JL, Freedman RS.
    Clin Cancer Res; 2002 Dec 01; 8(12):3686-95. PubMed ID: 12473577
    [Abstract] [Full Text] [Related]

  • 40. Serum biomarkers in head and neck squamous cell cancer.
    Kaskas NM, Moore-Medlin T, McClure GB, Ekshyyan O, Vanchiere JA, Nathan CA.
    JAMA Otolaryngol Head Neck Surg; 2014 Jan 01; 140(1):5-11. PubMed ID: 24232368
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 44.